Sign in

CIK 0001768224

  • Accelerated filer
  • Smaller reporting company

Arcturus Therapeutics Holdings Inc.

Sign in to watch
Ticker
ARCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 858-900-2660
Business address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $42.95 ($429,500)
  3. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $54.23 ($542,300)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $75.31 ($753,100)
  6. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $46.40 ($464,000)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Director sold 800,000 shares at an average $100.81 ($80,650,635)
  14. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $96.19 ($961,900)
  15. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $55.28 ($552,800)
  16. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $42.83 ($428,300)
  17. 4 Open-market sale Chief Scientific Officer & COO sold 10,000 shares at $45.16 ($451,600)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 6 of 8 · 149 filings